By binding to both vaccine antibodies and a protein frequently upregulated in tumors, a molecular bridge harnesses antiviral immunity to fight cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results